425 related articles for article (PubMed ID: 6971418)
1. [Controlled study of unspecific cellular immunity in cancer patients].
Dominioni L; Dionigi R; Prati U; Cividini F; Cincera M; Pavesi L; Della Cuna GR
Minerva Med; 1981 Mar; 72(12):733-40. PubMed ID: 6971418
[TBL] [Abstract][Full Text] [Related]
2. Postoperative immunologic monitoring of cancer patients undergoing radical surgery.
Dominioni L; Dionigi R; Zonta A; Prati U
Boll Ist Sieroter Milan; 1978 Nov; 57(5):612-22. PubMed ID: 314812
[TBL] [Abstract][Full Text] [Related]
3. Critical evaluation of lymphocyte functions in urological cancer patients.
Elhilali MM; Paika KD; Brosman S; Fahey JL
Cancer Res; 1976 Jan; 36(1):132-7. PubMed ID: 1082369
[TBL] [Abstract][Full Text] [Related]
4. Monitoring of nonspecific cell-mediated immunity in cancer patients. I. Frequent dissociation between the responses of skin tests to recall antigens and in vitro lymphocyte transformation.
Simmler MC; Rameau G; Chou MJ; Mathé G
Isr J Med Sci; 1976; 12(4-5):472-8. PubMed ID: 939695
[TBL] [Abstract][Full Text] [Related]
5. Assays of immunocompetence in the staging and prognosis of cancer.
Robinson JC
Surg Gynecol Obstet; 1981 Dec; 153(6):909-21. PubMed ID: 7029761
[TBL] [Abstract][Full Text] [Related]
6. Postoperative cell mediated immune response is better preserved after laparoscopic vs open colorectal resection in humans.
Whelan RL; Franklin M; Holubar SD; Donahue J; Fowler R; Munger C; Doorman J; Balli JE; Glass J; Gonzalez JJ; Bessler M; Xie H; Treat M
Surg Endosc; 2003 Jun; 17(6):972-8. PubMed ID: 12640542
[TBL] [Abstract][Full Text] [Related]
7. Quantitation of T- and B-lymphocytes in peripheral blood of patients with solid tumours. I. Relation to other parameters of in vivo and in vitro immune competence.
Harris J; Stewart T; Sengar DP; Hyslop D
Can Med Assoc J; 1975 Apr; 112(8):948-52. PubMed ID: 1079472
[TBL] [Abstract][Full Text] [Related]
8. Defective cell-mediated immunity in carcinoma of the prostate.
Thomas JW; Jerkins G; Cox C; Lieberman P
Invest Urol; 1976 Jul; 14(1):72-5. PubMed ID: 60303
[TBL] [Abstract][Full Text] [Related]
9. Some parameters of cell-mediated immunity in colon cancer patients.
Markova R; Argirova R; Boeva M
Neoplasma; 1980; 27(1):43-6. PubMed ID: 6966380
[TBL] [Abstract][Full Text] [Related]
10. Blastogenic transformation of lymphocytes following phytohaemagglutinin treatment in vitro in malignant lymphomas. I. Hodgkin's disease. (Correlation with immunity response of the cellular type and with the clinical status).
Libánský J; Lukásová M; Pinosová I
Neoplasma; 1973; 20(1):51-60. PubMed ID: 4702205
[No Abstract] [Full Text] [Related]
11. [Delayed-type skin reaction in children with malignant diseases].
Ebell W; Schmidt C; Wahn V; Göbel U
Klin Padiatr; 1985; 197(6):447-52. PubMed ID: 4087824
[TBL] [Abstract][Full Text] [Related]
12. Delayed cutaneous hypersensitivity and lymphocyte transformation: dissociation in atopic dermatitis.
Elliott ST; Hanifin JM
Arch Dermatol; 1979 Jan; 115(1):36-9. PubMed ID: 367287
[TBL] [Abstract][Full Text] [Related]
13. [Clinical usefulness of Multitest in the evaluation of cellular immunity].
Feijoó RM; Ardiles A; Lemp P; King A; Villamán JJ; Parra A; Silva M
Rev Med Chil; 1996 Mar; 124(3):327-36. PubMed ID: 9008945
[TBL] [Abstract][Full Text] [Related]
14. Immunologic defects in lung cancer patients.
Holmes EC; Golub SH
J Thorac Cardiovasc Surg; 1976 Feb; 71(2):161-8. PubMed ID: 1107678
[TBL] [Abstract][Full Text] [Related]
15. Some aspects of cell-mediated hypersensitivity in patients with melanoma.
Moszkowska G; Jassem J; Kondrat W; Kopacz A; Goszczyńska E
Arch Immunol Ther Exp (Warsz); 1980; 28(4):655-60. PubMed ID: 6970028
[TBL] [Abstract][Full Text] [Related]
16. In vivo and in vitro cell-mediated immunity in tuberculous meningitis.
El-Naggar AK; Higashi GI
J Clin Lab Immunol; 1982 May; 8(1):37-42. PubMed ID: 7047745
[TBL] [Abstract][Full Text] [Related]
17. [Cellular immunity indices in benign breast tumors].
Baisheva SA; Zhalgasbaeva GT; Kaliev IuSh; Mezinova NN
Vopr Onkol; 1980; 26(5):15-9. PubMed ID: 7385708
[TBL] [Abstract][Full Text] [Related]
18. [Immunological monitoring of brain tumors--prognosis based on T-lymphocyte subpopulations and skin testing for delayed hypersensitivity].
Yokoyama H; Nakadai M; Asou Y; Maeda T; Ogashiwa M; Takeuchi K
No To Shinkei; 1985 Feb; 37(2):193-9. PubMed ID: 3873952
[TBL] [Abstract][Full Text] [Related]
19. Immunologic aspects of malignant tumors.
Ariyan S
Clin Plast Surg; 1979 Apr; 6(2):125-142. PubMed ID: 313868
[No Abstract] [Full Text] [Related]
20. [Features of cellular immunity of chronic lympholeukemia].
Sinitsina AM; Zverkova AS
Vrach Delo; 1982; (10):49-51. PubMed ID: 6983781
[No Abstract] [Full Text] [Related]
[Next] [New Search]
